The heat-shock transcription factor HSF1 was recently shown to have a key role in the development of tumors associated with activation of Ras or inactivation of p53. Here, we show that HSF1 is required for the cell transformation and tumorigenesis induced by the human epidermal growth factor receptor-2 (HER2) oncogene responsible for aggressive breast tumors. Upon expression of HER2, untransformed human mammary epithelial MCF-10A cells underwent neoplastic transformation, formed foci in culture and tumors in nude mouse xenografts. However, expression of HER2 in MCF-10A cells with knockdown of HSF1 did not cause either foci formation or tumor growth in xenografts. The antitumorigenic effect of downregulation of HSF1 was associated with HER2-induced accumulation of the cyclin-dependent kinase inhibitor p21 and decrease in the mitotic regulator survivin, which resulted in growth inhibition and cell senescence. In fact, either knockout of p21 or overexpression of survivin alleviated these effects of HSF1 knockdown. The proliferation of certain human HER2positive breast cancer lines also requires HSF1, as its knockdown led to upregulation of p21 and/or decrease in survivin, precipitating growth arrest. Similar effects were observed with a small-molecular-weight inhibitor of the heat-shock response NZ28. The effects of HSF1 knockdown on the growth arrest and senescence of HER2expressing cells were associated with downregulation of heat-shock protein (Hsp)72 and Hsp27. Therefore, HSF1 is critical for proliferation of HER2-expressing cells, most likely because it maintains the levels of HSPs, which in turn control regulators of senescence p21 and survivin.
Introduction
Induction of heat-shock protein (Hsp)72, Hsp27 and other Hsps represents a highly conserved protective mechanism against environmental insults, which is predominantly regulated by the heat-shock transcription factor HSF1 (Lindquist and Craig, 1988; Sorger, 1991; Morimoto et al., 1992) . Recent reports showed that HSF1 has an essential role in the development of lymphomas in p53-deficient mice and of carcinomas in Ras tumor model (Dai et al., 2007; Min et al., 2007) . Moreover, HSF1 was shown to support proliferation of several cancer cell lines (Dai et al., 2007) , but specific mechanisms of these effects have not been explored.
Normal tissues or non-transformed cells usually express relatively low levels of Hsp72 and Hsp27, and these proteins are strongly upregulated following stressful treatments in an HSF1-dependent manner (Jolly and Morimoto, 2000) . On the other hand, many human tumors and cancer cell lines express Hsp72 or/and Hsp27 at elevated levels constitutively (Jaattela, 1999; Jolly and Morimoto, 2000; Mosser and Morimoto, 2004; Calderwood et al., 2006) . High levels of Hsp72 and Hsp27 correlate with metastasis, resistance to anticancer drugs and poor prognosis in many human cancers (Ciocca and Calderwood, 2005) . Previous results from this laboratory indicated that certain cancer cells become 'addicted' to high levels of Hsp72, as specific depletion of Hsp72 rapidly suppressed cell proliferation and precipitated senescence in several cancer lines, but not in untransformed epithelial cells (Yaglom et al., 2007; Gabai et al., 2009) . Interestingly, in different cancer cells distinct senescence signaling pathways were activated upon depletion of Hsp72, depending on the presence of either phosphatidylinositol 3-kinase, catalytic, alpha polypeptide or Ras oncogenes (Gabai et al., 2009) .
Constitutively elevated expression of Hsp72 and/or Hsp27 in cancers is often due to the HSF1-dependent mechanisms (although sometimes it is HSF1-independent) (Cai and Zhu, 2003; Wu et al., 2005) . However, the role of HSF1 in cancers may not be limited to regulating the expression of HSPs, as this transcription factor also controls expression of many other proteins (Cahill et al., 1996 (Cahill et al., , 1997 Singh et al., 2000 Singh et al., , 2002 Xie et al., 2002a, b) .
Human epidermal growth factor receptor-2 (HER2) is a member of the epidermal growth factor receptor tyrosine kinase family, which is overexpressed in 25-30% of human breast and ovarian cancers (Moasser, 2007) . Besides activating mitogenic pathways, HER2 can upregulate growth-inhibitory/senescence signaling (Trost et al., 2005) , suggesting that malignant transformation needs not only oncogene activation but also a shutdown of senescence pathways. Here, in addressing the role of HSF1 in HER2-induced tumorigenesis, we discovered that HSF1 controls senescence signaling initiated by HER2.
Results

Depletion of HSF1 inhibits the transformation ability of HER2
To investigate the role of HSF1 in neoplastic transformation, we depleted HSF1 from breast epithelial MCF-10A cells, and then introduced the HER2 oncogene. Briefly, late-passage MCF-10A cells were infected with control retrovirus or retrovirus expressing the small hairpin RNA (shRNA) against HSF1 (shHSF1), followed by puromycin selection, which resulted in more than 95% depletion of HSF1 ( Figure 1a ). These treatments did not affect cell viability, and only slightly diminished growth (see below in Figure 2a ), further indicating that HSF1 is dispensable for growth of untransformed cells. Then, cells were infected with retrovirus expressing the constitutively active HER2 mutant V664E, which led to increased expression of vimentin and formation of foci (Figures 1b and c), indicating that cells underwent neoplastic transformation. In contrast, expression of HER2 in shHSF1 cells led to merely mild upregulation of vimentin, and foci formation was inhibited ( Figure 1b and c), indicating that HSF1 is required for HER2-induced transformation in vitro. Of note, in contrast to late-passage cells, infection with HER2-expressing retrovirus of earlypassage MCF-10A cells did not cause transformation and triggered senescence even without HSF1 depletion (not shown).
If infection with shHSF1 retrovirus followed infection with HER2 retrovirus, downregulation of HSF1 still triggered senescence even in fully transformed MCF-10A cells (Supplementary Figure S1 ), indicating that HSF1 is necessary for the maintenance of growth of HER2-transformed cells.
To address the role of HSF1 in tumorigenesis in vivo, HER2-expressing control and shHSF1 cells were tested for their ability to form tumors in xenografts. Control HER2-expressing cells formed noticeable tumors at the injection site by day 3 post-injection ( Figure 1d ). However, HER2-expressing cells depleted of HSF1 could not form tumors at least until day 25. Two tumors appeared at days 26 and 35 post-injection, and these tumors were much smaller. Importantly, in both tumors control of HSF1 expression by shRNA was lost, and levels of HSF1 partially restored (Supplementary Figure S2 ), further supporting that in the absence of HSF1, HER2-induced tumors cannot be formed.
HER2 triggers growth arrest and senescence in cells with knockdown of HSF1
We investigated the effects of HSF1 on the growth rates of HER2-expressing cells. Control and shHSF1 cells HSF1 is essential for HER2-induced transformation L Meng et al were infected with HER2-expressing retrovirus or control retrovirus. On day 2 post-infection cells were plated, and the cell number was counted every 48 h. Knockdown of HSF1 caused slightly slower growth in normal MCF-10A cells (Figure 2a ). Similarly, a minor reduction of growth rate was seen upon expression of HER2. Importantly, when we expressed HER2 in HSF1-depleted cells, a significant growth inhibition was observed (Figure 2a ), associated with a significant change in cells' appearance, including enlarged, flattened morphology and extensive vacuolization reminiscent of senescence ( Figure 2b ). To assess senescence, cells were stained for the acidic b-galactosidase (b-gal) activity ( Figure 2c ). In control population, there was only 1% of b-gal-positive cells, and in shHSF1 cells, this fraction raised to 4%. HER2 expression in control MCF-10A cells led to a significant increase in b-galpositive population (B30%). Importantly, expression of HER2 in shHSF1 MCF10A cells resulted in about 70% of b-gal-positive cells (Figure 2c ). Therefore, HSF1 seems to be critical for growth upon expression of HER2 because it keeps HER2-induced growth arrest and senescence under control.
p21 is a mediator in HER2-induced senescence upon depletion of HSF1 p21 Cip is the major regulator of senescence in cancer cells (Roninson, 2003) . Expression of HER2 leads to upregulation of p21 in MCF7 cells (Trost et al., 2005) . Therefore, we tested for the role of p21 in senescence caused by expression of HER2 in shHSF1 cells. p21 was mildly upregulated by HER2 expression in control cells, and knockdown of HSF1 on its own also led to a similar minor increase in p21 levels ( Figure 3a ). However, there was a marked induction of p21 upon expression of HER2 in shHSF1 cells (Figure 3a ). To investigate the role of p21 in the onset of senescence under these conditions, wild-type and p21 knockout MCF-10A cells (kind gift from Dr Park; Bachman et al., 2004) were infected with shHSF1 and control retroviruses, followed by brief puromycin selection. Then, cells were infected with a virus expressing HER2, and plated to monitor senescence. In contrast to wild-type cells, in p21 knockout cells, the combination of shHSF1 and HER2 expression did not cause significant growth inhibition or senescence, as judged by cell morphology (Figure 3b ). HSF1 is essential for HER2-induced transformation L Meng et al Further, we tested whether suppression of senescence in the p21 knockout cells can restore tumor development in HSF1 knockdown cells. Control and p21 knockout cells were depleted of HSF1, and then infected with HER2 retrovirus and injected into nude mice to establish xenograft tumors. As seen in Figure 3c , in contrast to wild-type cells, depletion of HSF1 had only a mild inhibitory effect on tumor development by p21 knockout cells. Therefore, suppression of senescence by p21 knock-out was sufficient to restore tumor growth, indicating that HER2-triggered senescence of HSF1-depleted cells represents the major barrier for tumor development.
Survivin is involved in HER2-induced senescence upon depletion of HSF1 We noticed a decrease in survivin levels upon expression of HER2 in shHSF1 cells (see below). Survivin, a member of the inhibitors of apoptosis (IAPs) family, is Figure 3 p21 is involved in human epidermal growth factor receptor-2 (HER2)-induced senescence in HSF1-deficient cells. (a) p21 levels in control (Cont.) and small hairpin RNA against HSF1 (shHSF1) MCF-10A cells with (HER2) or without (empty vector, EV) HER2 overexpression. (b) Cell morphology in wild-type (WT) and p21 knockout (p21KO) MCF-10A cells with same retrovirus infections as in (a). Pictures were taken at day 4 post-infection. Whitish masses represent the foci. (c) WT and p21 knockout (KO) MCF-10A cells were treated with Cont. or shHSF1 retroviruses, followed by HER2 overexpression. Growth curves of xenograft tumors from these HER2-expressing cells were shown.
HSF1 is essential for HER2-induced transformation L Meng et al a critical regulator of proliferation (Altieri, 2003) . Upon HER2 expression, survivin levels were dramatically decreased in shHSF1 cells, but not in control cells (Figure 4a ). Knockout of p21 suppressed the decrease in survivin after expression of HER2 in shHSF1 cells, indicating that downregulation of survivin is at least partially p21-dependent (Figure 4a ). On the other hand, in other cell lines, the decrease in survivin levels was p21independent (see below), indicating an alternative mechanism of the survivin control.
To test the role of survivin in HER2-induced senescence, we infected control and shHSF1 cells with a retrovirus expressing survivin, and following brief selection, infected the cells with HER2-expressing virus. Survivin overexpression restored growth and rescued senescence phenotype in HSF1-knockdown cells upon HER2 expression, as judged by cell morphology and b-gal activity staining (Figures 4b and c) , indicating that survivin is important for regulation of growth inhibition and senescence under these conditions. We further investigated the effects of HSF1 depletion on HER2-positive human cancer cell lines SK-BR-3 (having mutant p53) and MDA-MB-453 (having wild-type p53). HSF1 was depleted in these cell lines using a retroviral vector, as described above. In both cell lines, infection with shHSF1 retrovirus led to more than 80% depletion of HSF1 (Figures 5a and b) . As with MCF-10A cells, HSF1 depletion in MDA-MB-453, which has normal p53 (Lacroix et al., 2006) , led to induction of p21, as well as slight downregulation of survivin (Figure 5a ). Knockdown of HSF1 in SK-BR-3 cells led to strong downregulation of survivin (Figure 5b ), but no upregulation of p21 (not shown). As SK-BR-3 cells have mutant p53 (Lacroix et al., 2006) , these data indicate that the effect of HSF1 on survivin could be independent of p53, whereas its effect on p21 appears to be p53dependent. As expected, in both MDA-MB-453 and SK-BR-3 cells, alterations of survivin and/or p21 upon HSF1 depletion were associated with growth inhibition (Figures 5a and b , lower panels). Of note, these cell lines did not show signs of senescence in spite of growth arrest. This observation suggests that in certain cancer lines at least some components of the senescence program are defective. Overall, these data indicate that in HER2-positive human cell lines, HSF1 serves an important function in supporting cell proliferation by regulation of p21 and/or survivin.
Heat-shock response inhibitor NZ28 suppresses HER2-induced transformation NZ28, a small-molecular-weight inhibitor of heat-shock response that we recently developed (Zaarur et al., 2006) , was used to further address the role of HSF1 in HER2-induced cell transformation. MCF-10A cells were infected with HER2-expressing retrovirus, and NZ28 was administered to cells 2 days after infection. Incubation with 1 mM of NZ28 for 3 days led to reduction of the Hsp72 levels in HER2-expressing cells (Figure 5c ), which were associated with growth inhibition (see below). NZ28 treatment also significantly suppressed foci formation in HER2-overexpressing MCF-10A cells (Figure 5c ). In fact, in control untransformed cells, 1 mM of NZ28 caused only minor growth inhibition, whereas in HER2-expressing cells, the inhibition was more than 70% (Figure 5c, right panel) . Importantly, treatment with NZ28 led to a strong downregulation of survivin (Figure 5c ), whereas the p21 levels were not significantly changed (not shown), also pointing toward additional effects of this drug.
In HER2-positive human cancer lines, the effects of incubation with NZ28 (5 mM) for 3 days, in general, were similar to the effects of HSF1 depletion. Indeed, we observed strong downregulation of Hsp72, a decrease of HSF1 levels, downregulation of survivin and growth inhibition (Figure 5d ). Overall, these results indicate that inhibition of HSF1 or its knockdown can prevent HER2-induced cell transformation and suppress proliferation of HER2-expressing tumor cells.
Effects of HSF1 on HER2-induced transformation may be related to expression of Hsps
Hsp90, one of the major HSF1 targets, has an important role in the activity and stability of cancer-related signaling proteins (Pratt and Toft, 2003) . Therefore, the effects of HSF1 on tumorigenesis could be related to the control of Hsp90. However, we did not observe downregulation of major Hsp90 client proteins Akt, a-MET and glycogen synthase kinase-3b, and activation of ERK1/2 was not reduced in shHSF1 cells (Figure 6b) . Therefore, the effects of HSF1 knockdown on HER2induced growth inhibition and senescence are unrelated to downregulation of Hsp90.
The control of senescence could be specifically linked to the expression of Hsp72, as this Hsp regulates senescence signaling pathways (Yaglom et al., 2007; Gabai et al., 2009) . Indeed, we observed significant upregulation of both Hsp72 and Hsp27 following HER2 expression, which was fully dependent on HSF1 (Figure 6c ). This finding is in line with previous study that demonstrated that HER2/HER3 ligand heregulin induces Hsp72 in an Hsf1-dependent manner (Khaleque et al., 2005) . Notably, there is no change in the levels of Hsp70-2 (Supplementary Figure S3) .
We tested whether prevention of induction of Hsp72 and/or Hsp27 is involved in the HER2-triggered senescence. Infection with shHsp72 or shHsp27 retroviruses brought about depletion of these chaperones by more than 70% (Figure 6d ). No significant effect on either cell morphology or growth was seen under these conditions in untransformed MCF-10A cells (Figure 6e ). However, subsequent expression of HER2 rapidly triggered senescence (Figure 6e ). Therefore, lack of Hsp72 or Hsp27 is sufficient for senescence triggered by HER2, which may explain the effects of depletion of HSF1 on HER2-triggered senescence.
Discussion
Here we discovered that HSF1 has a critical role in HER2-induced tumorigenesis in mammary epithelial cells. In fact, depletion of HSF1 strongly suppressed both transformation judged by foci formation in culture and tumor development in xenografts. The suppression of transformation was associated with a paradoxical effect of HER2 on cells that lacked HSF1. Upon expression of HER2, instead of transformation these cells stopped proliferating and underwent senescence. These data strongly suggest that HER2 activates both mitogenic and senescence signals, and HSF1 serves in suppression of senescence. Accordingly, in cells that lack HSF1, senescence signals prevail and proliferation stops.
In part, growth inhibition signaling was owing to the cell cycle inhibitor p21. HER2 was able to mildly upregulate p21 even in naı¨ve cells. However, p21 induction was much stronger in cells with depleted HSF1. Furthermore, p21 knockout suppressed the senescence phenotype triggered by HER2.
HSF1 is essential for HER2-induced transformation L Meng et al Interestingly, in addition to p21, which is a known player in the oncogene-induced senescence, we uncovered a novel role of survivin in this process. Survivin is homologous to IAPs, and originally was found to suppress apoptosis (Altieri, 2003a) . In addition, survivin regulates mitosis by modulation of aurora B kinase (Altieri, 2008) . Here, we found that survivin was downregulated in cells with HSF1 knockdown upon Figure 5 HSF1 is critical for proliferation of human epidermal growth factor receptor-2 (HER2)-positive human cancer cells. MDA-MB-453 (a) and SK-BR3 (b) cells were infected with small hairpin RNA against HSF1 (shHSF1) retrovirus, and selected with puromycin. The levels of HSF1, p21 and survivin were assessed by immunoblotting on day 10 post-infection (a, b, upper panels). Cell number was assessed starting on day 7 post-infection (a, b, lower panels). (c) MCF-10A cells were infected with HER2-expressing retrovirus, selected for 2 days and incubated with NZ28 for additional 2 days. Then, the levels of heat-shock protein (Hsp72) and survivin, and foci formation ability were assessed. Dark masses represent foci stained with hematoxylin. Effects of NZ28 on growth rate of MCF-10A cells were also determined (right panel). (d) MDA-MB-453 and SK-BR3 cells were incubated with 2 and 5 mM NZ28 for 3 days and the levels of HSF1, Hsp72 and survivin were measured by immunoblotting (upper panels). Effect of NZ28 on growth of SK-BR3 cells was determined by cell counting with hemocytometer (lower panel).
HSF1 is essential for HER2-induced transformation L Meng et al expression of HER2, and, importantly, ectopic expression of survivin suppressed senescence under these conditions. Expression of survivin was previously shown to be regulated by p21 (Altieri, 2003a) , and indeed the survivin decrease was partially suppressed in p21 knockout cells. On the other hand, the survivin decrease was partially p21-independent, indicating that a distinct signaling pathway controlled by HSF1 regulates survivin levels. Analyses of HER2-positive human cancer cells suggested that even in SK-BR-3 line with mutant HSF1 is essential for HER2-induced transformation L Meng et al p53 that has undetectable levels of p21, HSF1 depletion led to survivin decrease and precipitated senescence, indicating a p21-independent pathway of survivin regulation. At least in part, HSF1-mediated control of cancer cell senescence was due to the regulation of expression of Hsp72 and Hsp27. In fact, if either Hsp72 or Hsp27 was depleted, expression of HER2 also brought about senescence instead of transformation, indicating that downregulation of any of these Hsps is sufficient for the paradoxical effects of HER2. In line with this notion, overexpression of Hsp72 alone was not sufficient for reversing the effect of depletion of HSF1 on senescence. Furthermore, analyses of various human cancer cell lines indicated that there was an association between the senescence (or growth inhibition) in response to HSF1 and depletion of Hsp72. There is a possibility that a general decline of protein homeostasis contributes to the oncogene-induced senescence. On the other hand, it is currently clear that HSF1 may have other effects on tumorigenesis unrelated to the expression of Hsp72. In fact, HSF1 was found to regulate proinflammatory cytokines (Cahill et al., 1997; Xie et al., 2002b) , translational machinery, glucose metabolism (Dai et al., 2007) and cooperate with the invasionassociated protein MTA (Khaleque et al., 2008) , which obviously may contribute to tumor development. Very importantly, we observed that HER2 expression triggers growth arrest in MCF-10A cells treated with a small-molecular-weight inhibitor of heat-shock response, NZ28. Originally, we developed this inhibitor to enhance anticancer activities of the proteasome and Hsp90 inhibitors (Zaarur et al., 2006) . Here, we found that it inhibits growth of MCF-10A cells that express HER2, as well as HER2-positive cancer lines. These findings support the idea that HSF1 could be an interesting drug target for treatment of HER2-positive herceptin-resistant cancers.
Materials and methods
Cell cultures and reagents MCF-10A wild-type and p21 À/À cells were cultured in Dulbecco's modified Eagle's medium/F12 medium supplemented with 5% horse serum, 20 ng/ml epidermal growth factor, 0.5 mg/ml hydrocortisone, 10 mg/ml human insulin and 100 ng/ ml cholera toxin. HEK293T, SK-BR3 and MDA-MB-453 cells were from ATCC (Manassas, VA, USA). HEK293T cells were cultivated in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum. All other cells were cultivated in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum.
Retroviral vectors and infection
RNAi-Ready pSIREN-RetroQ vector from BD Biosciences (San Jose, CA, USA) retroviral delivery system was used for knockdown of HSF1. The sequence of human HSF1 gene was selected as reported before (Zaarur et al., 2006) : 5 0 -TATGGA CTCCAACCTGGATAA-3 0 . HER2 and control (pBABE) retroviral vectors were a kind gift from C Spangenberg (Trost et al., 2005) . This version of HER2 carries the activating V664E mutation (NeuT). Retroviruses were produced as reported before (Yaglom et al., 2007; Gabai et al., 2009) . Briefly, HEK293T cells were co-transfected with plasmids expressing retroviral proteins Gag-Pol, vesicular stomatitis virus glycoprotein pseudotype and enhanced green fluorescent protein or our constructs using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). At 48 h after transfection, supernatants containing the retroviral particles were collected and frozen at À70 1C until use. MCF-10A cells were infected with diluted supernatant in the presence of 10 mg/ml Polybrene overnight, and were selected with puromycin (0.75 mg/ml) 48 h after infection. Retroviral vectors expressing enhanced green fluorescent protein was used as infection efficiency indicator: usually B90% of cells were fluorescent 2 days after infection.
Mouse xenografts
Animal maintenance and experiments were conducted in compliance with the guidelines of the Institutional Animal Care and Use Committee. Briefly, HER2-infected MCF-10A cells with or without shHSF1 were trypsinized, mixed at 1:1 ratio with matrigel and 0.25 million cells of each culture were injected subcutaneously into 6-week-old female NCR nude mice (Taconic, Hudson, NY, USA). Tumor growth was monitored weekly.
Immunoblot analysis
Cells were washed twice with phosphate-buffered saline and lysed in lysis buffer (40 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (pH 7.5), 50 mM KCl, 1% Triton X-100, 1 mM Na 3 VO 4 , 50 mM glycerophosphate, 50 mM NaF, 5 mM EDTA, 5 mM ethylene glycol tetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1 mM benzamidine and 5 mg/ml each leupeptin, pepstatin A and aprotinin). The protein concentration of the lysates was measured with the Bio-Rad protein assay reagent, after which they were diluted with lysis buffer to achieve equal protein concentrations. The antibodies used for this study were listed as follows: anti-AKT, anti-pERK, anti-ERK, anti-a-MET and anti-glycogen synthase kinase-3b from Cell Signaling (Danvers, MA, USA); anti-HSF1, anti-Hsp90, anti-Hsp72 and anti-Hsp27 from Stressgen (Ann Arbor, MI, USA); anti-p21 and anti-PARP from BD PharMingen (San Jose, CA, USA); anti-vimentin from LabVision (Thermo Scientific, Fremont, CA, USA); anti-survivin from Santa Cruz (Santa Cruz, CA, USA); and anti-b-actin from Sigma (St Louis, MO, USA).
b-Galactosidase assay b-Galactosidase assay was carried out using X-gal (5-bromo-4chloro-3-indolyl b-D-galactopyranoside) (pH 6.0) as described previously (Yaglom et al., 2007; Gabai et al., 2009) . Cells were plated at a low density and fixed with 2% formaldehyde and 0.2% glutaraldehyde. The b-gal activity was determined by incubation with 1 mg/ml of solution of X-gal in 40 mM sodium citrate, 5 mM K 3 FeCN 6 , 5 mM K 4 FeCN 6 , 150 mM NaCl and 2 mM MgCl 2 diluted in phosphate-buffered saline (pH 6.0). The number of stained cells was counted under a microscope from five different fields and the proportion of stained cells was calculated. The results were expressed as mean value±s.d. on three independent experiments.
Cell growth and foci formation Cell growth curve was performed by seeding 5000 cells per well in 12-well plate and cell number was monitored every 2 days. To study foci formation, cells were seeded at 3 Â 10 5 per well in a six-well plate and were let to grow for 2 days until the foci could be observed under the microscope. Then, cells were washed twice with phosphate-buffered saline, fixed with 2% formaldehyde/0.2% glutaraldehyde in phosphate-buffered saline for 10 min and stained with hematoxylin.
